BACKGROUND AND PURPOSE
The use of human intestinal alkaline phosphatase (IAP) has already been
validated as a novel treatment for endotoxin lipopolysaccharide
(LPS)-induced inflammatory diseases, which is mediated through IAP’ s
ability to detoxify LPS. However, there has been little investigation
into the full extent of IAP’ s physiological function. This study
investigates IAP’s non-LPS related functions and clinical applications.